These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8251610)

  • 21. Influence of midazolam on pharmacokinetics of verapamil in rabbits.
    Orszulak-Michalak D; Owczarek J; Wiktorowska-Owczarek AK
    Pol J Pharmacol; 2002; 54(5):501-6. PubMed ID: 12593537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of the ginkgo B following intravenous administration of ginkgo B emulsion in rats.
    Chen WD; Liang Y; Xie L; Lu T; Liu XD; Wang GJ
    Biol Pharm Bull; 2007 Jan; 30(1):1-5. PubMed ID: 17202649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil.
    Krecic-Shepard ME; Barnas CR; Slimko J; Schwartz JB
    Clin Pharmacol Ther; 2000 Sep; 68(3):286-92. PubMed ID: 11014410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of prolonged submaximal exercise on the pharmacokinetics of verapamil in humans.
    Mooy J; Arends B; van Kemenade J; Boehm R; Rahn KH; van Baak M
    J Cardiovasc Pharmacol; 1986; 8(5):940-2. PubMed ID: 2429094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacokinetics of racemic verapamil in patients with impaired renal function.
    Zachariah PK; Moyer TP; Theobald HM; Frantz RP; Kurtz SB; McCarthy JT; Smith RL
    J Clin Pharmacol; 1991 Jan; 31(1):45-53. PubMed ID: 2045528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic and pharmacodynamic effects of high-dose continuous intravenous verapamil infusion: clinical experience in the intensive care unit.
    De Cicco M; Macor F; Robieux I; Zanette G; Fantin D; Fabiani F; Nicolosi G; Fracasso A; Toffoli G; Santantonio C; Lestuzzi C; Matovic M; Boiocchi M
    Crit Care Med; 1999 Feb; 27(2):332-9. PubMed ID: 10075058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry.
    Yang B; Wang X; Liu W; Zhang Q; Chen K; Ma Y; Wang C; Wang Z
    J Ethnopharmacol; 2013 Oct; 149(3):810-5. PubMed ID: 23954278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosing.
    Busse D; Fromm MF; Mörike K; Drescher S; Kühlkamp V; Eichelbaum M
    Clin Pharmacol Ther; 2001 May; 69(5):324-32. PubMed ID: 11372000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the hepatic blood flow rate model for verapamil first-pass metabolism.
    Popović J
    Eur J Drug Metab Pharmacokinet; 2007; 32(1):13-9. PubMed ID: 17479539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The chimpanzee (Pan troglodytes) as a pharmacokinetic model for selection of drug candidates: model characterization and application.
    Wong H; Grossman SJ; Bai SA; Diamond S; Wright MR; Grace JE; Qian M; He K; Yeleswaram K; Christ DD
    Drug Metab Dispos; 2004 Dec; 32(12):1359-69. PubMed ID: 15333515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data.
    Hsiao P; Sasongko L; Link JM; Mankoff DA; Muzi M; Collier AC; Unadkat JD
    J Pharmacol Exp Ther; 2006 May; 317(2):704-10. PubMed ID: 16415090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The inhibitory effects of cimetidine on elimination and distribution of propranolol in rats.
    Shibasaki S; Asahina M; Kawamata Y; Kojo M; Nishigaki R; Umemura K
    J Pharmacobiodyn; 1989 Sep; 12(9):549-57. PubMed ID: 2614643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enantioselective tissue distribution of the basic drugs disopyramide, flecainide and verapamil in rats: role of plasma protein and tissue phosphatidylserine binding.
    Hanada K; Akimoto S; Mitsui K; Mihara K; Ogata H
    Pharm Res; 1998 Aug; 15(8):1250-6. PubMed ID: 9706057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacology of verapamil. III. Pharmacokinetics in normal subjects after intravenous drug administration.
    Dominic JA; Bourne DW; Tan TG; Kirsten EB; McAllister RG
    J Cardiovasc Pharmacol; 1981; 3(1):25-38. PubMed ID: 6160352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.
    Carosella L; Menichelli P; Alimenti M; Zuccala G; Gemma A; Cocchi A; Carbonin PU
    Cardiovasc Drugs Ther; 1989 Jun; 3(3):417-25. PubMed ID: 2487538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid analysis of verapamil in plasma by reversed phase HPLC.
    Yazan Y; Bozan B
    Pharmazie; 1995 Feb; 50(2):117-9. PubMed ID: 7700964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct determination of verapamil in rat plasma by coupled column microbore-HPLC method.
    Jhee OH; Hong JW; Om AS; Lee MH; Lee WS; Shaw LM; Lee JW; Kang JS
    J Pharm Biomed Anal; 2005 Feb; 37(2):405-10. PubMed ID: 15708686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-linear pharmacokinetics of high-dose intravenous verapamil.
    Toffoli G; Robieux I; Fantin D; Gigante M; Frustaci S; Nicolosi GL; De Cicco M; Boiocchi M
    Br J Clin Pharmacol; 1997 Sep; 44(3):255-60. PubMed ID: 9296319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of pioglitazone on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rats.
    Choi JS; Burm JP
    Arch Pharm Res; 2008 Sep; 31(9):1200-4. PubMed ID: 18806964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.